Crizotinib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell Lymphoma
Sponsor and Collaborators
Children’s Oncology Group
National Cancer Institute (NCI)
Click here for contact info
Yael P. Mosse, MD
Children’s Hospital of Philadelphia
Next post in Lymphoma Clinical Trials
Want to view more content from Cancer Therapy Advisor?
Register now at no charge to access unlimited clinical news, full-length features, case studies, conference coverage, and more.
Want to read more?
Please login or register first to view this content.